Screener
Emergent Biosolutions EBS Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 666.0 | 662.5 |
| Property, plant and equipment, net | 178.0 | 205.4 |
| Intangible assets, net | 261.8 | 436.5 |
| Other assets | 11.0 | 14.2 |
| Total assets | $1,116.8 | $1,318.6 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $50.2 | $55.6 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Emergent Biosolutions's other non-current assets?
- Emergent Biosolutions (EBS) reported other non-current assets of $11M in Q2 2026.
- How has Emergent Biosolutions's other non-current assets changed year-over-year?
- Emergent Biosolutions's other non-current assets increased by 50.7% year-over-year, from $7.3M to $11M.
- What is the long-term trend for Emergent Biosolutions's other non-current assets?
- Over 5 years (2020 to 2025), Emergent Biosolutions's other non-current assets has grown at a -34.0% compound annual growth rate (CAGR), from $113.4M to $14.2M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Emergent Biosolutions's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude